Skip to main content

Real-world evidence and health economics outcomes research

Congress materials

Obesity

 Obesity | PDF

 

2026: A 5-year financial impact of employer coverage of semaglutide for patients with obesity

 

Diabetes

 Diabetes | PDF

 

2025: Adherence to once-weekly injectable semaglutide and associated risk factors in patients with type 2 diabetes in the United States

 

 Diabetes | PDF

 

2025: Oral semaglutide adherence and associated risk factors in patients with type 2 diabetes in the United States

 

Cardiovascular

 Cardiovascular Disease | PDF

 

2026: Systemic Inflammation and Its Association with Major Adverse Cardiovascular Events in Patients with Acute Myocardial Infarction​

 

 Cardiovascular Disease | PDF

 

NEXUS 2025: Economic Burden Associated with Systemic Inflammation in Patients with Established Atherosclerotic Cardiovascular Disease and Stage 3-4 Chronic Kidney Disease​

 

Liver Health

 Liver Health | PDF

 

NEXUS 2025: Healthcare Resource Utilization and Costs in Patients with Metabolic Dysfunction-Associated Steatohepatitis: A Comparison Between Patients with Probable MASH, Without MASH, and Diagnosed MASH

 

 Liver Health | PDF

 

NEXUS 2025: Real-World Healthcare Resource Utilization and Costs Among 100% Fee-For-Service Medicare Beneficiaries With Metabolic Dysfunction-Associated Steatohepatitis

 

Rare Bleeding Disorders

 Hemophilia | PDF

 

2025: Resource utilization and economic burden amongst a cohort of patients with hemophilia with inhibitors in the United States​

 

 Hemophilia | PDF

 

NEXUS 2025: Assessing Costs and Healthcare Resource Utilization in Non-Inhibitor Hemophilia A and B Patients in the United States

 

Hemoglobinopathies

 Hemoglobinopathies | PDF

 

NEXUS 2025: Association of Acute Pain and Fatigue on Health Care Resource Utilization and Costs in Patients With Sickle Cell Disease in the United States

 

Search Novo Nordisk Medical

Novo Nordisk Medical is a resource for U.S. Healthcare Professionals to learn more about disease states investigated by Novo Nordisk and our related products. It provides evidence-based information on a variety of topics important to patient care. All information is for educational purposes only and is not intended to promote any products.

Find more information

Phone icon

Find product information

Explore our portfolio of products, including prescribing information, safety data sheets, and storage and stability information.

Continuing education

Learn about accredited disease education opportunities supported by Novo Nordisk and provided by third-party organizations.

Phone icon